Search
Dexcom Inc
DXCMAdd to Watchlist
82.290USD
+2.360+2.95%
Close 10-30 16:00（ET）
31.05BMarket Cap
34.42P/E TTM
Dexcom Inc (DXCM) Stock Price Target & Forecast
Analyst Rating
Based on 29 analysts giving stock ratings to Dexcom Inc in the past month.
Buy
13 Strong Buy
12 Buy
4 Hold
0 Sell
0 Strong Sell
Target Price
95.920USD+22.00%
DXCM Analyst Recommendation Trends
In the current month, DXCM has received 12 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. DXCM average Analyst price target in the last month is 95.920.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
13
13
13
13
13
13
13
13
12
13
13
15
14
14
14
13
4
4
4
4
4
3
3
4
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
29
30
30
32
31
31
31
31
DXCM Analyst Rating for Peer Comparison
Updated: Oct 29, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Abbott Laboratories
ABT
10
13
6
0
0
29
Stryker Corp
SYK
11
13
5
0
0
29
Medtronic PLC
MDT
8
11
10
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
6
20
0
0
28
Guardant Health Inc
GH
12
13
2
0
0
27
Insulet Corp
PODD
7
7
12
0
0
26
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
13
3
0
0
21
Alcon AG
ALC
6
9
3
1
0
19
Financial Forecasting
Based on analysts' estimates, DXCM EPS is projected to reach 0.719 in FY2026Q4, following reported EPS of 0.734 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
0.47
0.61
0.67
0.72
0.64
Actual
0.52
0.65
0.73
--
--
Surprise
+10.43%
+6.73%
+8.94%
--
--
FAQs
What is Dexcom Inc's expected revenue for the next quarter?
Dexcom Inc's expected revenue is 1.39B.
What is Dexcom Inc's price target?
Analysts forecast that Dexcom Inc's price target is USD 95.92, with the highest forecast at USD 115.00 and the lowest forecast at USD 75.00.
How have Dexcom IncDXCM's recent earnings per share performed?
The market expectation was USD 0.73, while Dexcom IncDXCM's earnings per share (EPS) for the previous quarter was USD 0.65. EPS for the next quarter is expected at USD 0.72.
What is the analyst rating for Dexcom Inc?
Based on the ratings of Dexcom Inc's stock from 29 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.